Industries · 325 Chemical Manufacturing
Pharmaceutical and Medicine Manufacturing
NAICS 3254 · detail · PAC industry group on the money pages: Health
22 laws and 239 sections whose text names, amends, funds or regulates something in this industry.
Automated tagging from the law’s text and public spending records, by fixed published rules; not reviewed by a person. A tag says a section names, amends, funds or regulates something in an industry. It doesn’t say the law helps or hurts that industry. How tags are made
S. 1071 · 119th Congress
National Defense Authorization Act for Fiscal Year 2026
2 sections · medium confidence
Show 2 sections and the evidence
Sec. 3111 Organization and codification of provisions of law relating to atomic energy defense activities
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 7261 Policy and briefing on availability of naloxone to treat opioid, including Fentanyl, overdoses
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
S. 331 · 119th Congress
HALT Fentanyl Act
5 sections · medium confidence
Show 5 sections and the evidence
Sec. 2 Class scheduling of fentanyl-related substances
Sec. 3 Registration requirements related to research
- “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
- “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 4 Technical correction on controlled substances dispensing
Sec. 6 Penalties
Sec. 7 Applicability; other matters
S. 146 · 119th Congress
Tools to Address Known Exploitation by Immobilizing Technological Deepfakes on Websites and Networks Act
1 section · low confidence
H.R. 7148 · 119th Congress
Consolidated Appropriations Act, 2026
11 sections · high confidence
Show 11 sections and the evidence
Sec. 509 (a) None of the funds made available in this Act may be used for…
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
Sec. 6221 Medicare coverage of multi-cancer early detection screening tests
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6224 Modernizing and ensuring PBM accountability
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6601 Research into pediatric uses of drugs; additional authorities of Food and Drug Administration regarding molecularly targeted cancer drugs
- “21 U.S.C. 355c” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
- “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 6602 Ensuring completion of pediatric study requirements
Sec. 6603 FDA report on PREA enforcement
Sec. 6604 Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases
Sec. 6605 Limitations on exclusive approval or licensure of orphan drugs
Sec. 6611 Establishment of Abraham Accords Office within Food and Drug Administration
Sec. 6703 Increasing transparency in generic drug applications
H.R. 7147 · 119th Congress
Homeland Security and Further Additional Continuing Appropriations Act, 2026.
1 section · medium confidence
Show 1 section and the evidence
Sec. 227 None of the funds made available in this Act for U.S. Customs and Border…
H.R. 5371 · 119th Congress
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
21 sections · high confidence
Show 21 sections and the evidence
The “Salaries and Expenses” paragraph Salaries and Expenses
The “Buildings and Facilities” paragraph Buildings and Facilities
- “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
Sec. 722 None of the funds made available by this Act may be used to propose,…
Sec. 734 None of the funds made available by this Act may be used to notify…
Sec. 735 None of the funds made available by this or any other Act may be…
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 772 (a) Of the amounts made available in this Act under the heading Department of…
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 773 (a) Fees derived from amounts assessed and collected for fiscal year 2026, credited under…
Sec. 777 For purposes of applying the Federal Food Drug, and Cosmetic Act (21 U.S.C. 301…
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 780 No funds appropriated by this Act may be used to administer or enforce the…
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 781 Effective 365 days after the enactment of this Act, Section 297A of the Agricultural…
Sec. 785 The Commissioner of the Food and Drug Administration shall develop a report to determine…
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 6502 Finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6503 Definitions
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6504 Authority to assess and use OTC monograph fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6505 Reauthorization; reporting requirements
Sec. 6506 Treatment of active ingredients for topical administration
Sec. 6507 Increasing the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches
Sec. 6508 Regulation of certain nonprescription drugs that are marketed without an approved drug application
Sec. 6509 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6510 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 6511 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 2483 · 119th Congress
SUPPORT for Patients and Communities Reauthorization Act of 2025
6 sections · medium confidence
Show 6 sections and the evidence
Sec. 112 Assessment of opioid drugs and actions
Sec. 207 Grants to enhance access to substance use disorder treatment
- “21 U.S.C. 823” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
Sec. 209 Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone
- “21 U.S.C. 811” in the text · Rule a (a:usc-21-csa) · low confidence · Source
- “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 210 References to opioid overdose reversal agents in HHS grant programs
Sec. 401 Delivery of a controlled substance by a pharmacy to a prescribing practitioner
- “21 U.S.C. 829a” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
- “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 402 Required training for prescribers of controlled substances
H.R. 9747 · 118th Congress
Continuing Appropriations and Extensions Act, 2025
1 section · high confidence
Show 1 section and the evidence
H.R. 5860 · 118th Congress
Continuing Appropriations Act, 2024 and Other Extensions Act
13 sections · low confidence
Show 13 sections and the evidence
Sec. 2301 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2302 Definitions
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2303 Authority to assess and use animal drug fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2304 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2305 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2306 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2307 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2311 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2312 Authority to assess and use generic new animal drug fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2313 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2314 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2315 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2316 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 5009 · 118th Congress
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
4 sections · medium confidence
Show 4 sections and the evidence
Sec. 707 Contraception coverage parity under the TRICARE program
Sec. 739 Plan to improve access by members of the Armed Forces to safe, high-quality pharmaceuticals
- “Pharmaceutical” in the text · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 850 Report and updated guidance on continued risk management for pharmaceutical supply chains of Department of Defense
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 7807 Fentanyl reporting and authorities
- “21 U.S.C. 802” in the text · Rule a (a:usc-21-csa) · low confidence · Source
H.R. 4366 · 118th Congress
Consolidated Appropriations Act, 2024
7 sections · medium confidence
Show 7 sections and the evidence
The “Salaries and Expenses” paragraph Salaries and Expenses
The “Buildings and Facilities” paragraph Buildings and Facilities
- “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
The “Fda Innovation Account, Cures Act” paragraph Fda Innovation Account, Cures Act
- “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
Sec. 722 None of the funds made available by this Act may be used to propose,…
Sec. 737 None of the funds made available by this Act may be used to notify…
Sec. 745 (a) After the effective date of any final rule the Food and Drug Administration…
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 754 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
H.R. 2882 · 118th Congress
Udall Foundation Reauthorization Act of 2023
3 sections · medium confidence
Show 3 sections and the evidence
Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
Sec. 509 (a) None of the funds made available in this Act may be used for…
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
H.R. 2670 · 118th Congress
National Defense Authorization Act for Fiscal Year 2024
3 sections · medium confidence
Show 3 sections and the evidence
Sec. 716 Establishment of military pharmaceutical and medical device vulnerability working group
- “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 723 Program of the Department of Defense to study treatment of certain conditions using certain psychedelic substances
- “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- “21 U.S.C. 812” in the text · Rule a (a:usc-21-csa) · low confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 725 Study and report on health conditions of members of the Armed Forces on active duty developed after administration of COVID–19 vaccine
H.R. 815 · 118th Congress
RELIEVE Act
1 section · low confidence
S. 1605 · 117th Congress
National Defense Authorization Act for Fiscal Year 2022
3 sections · medium confidence
Show 3 sections and the evidence
Sec. 716 Establishment of Department of Defense system to track and record information on vaccine administration
Sec. 744 Briefing on domestic production of critical active pharmaceutical ingredients for national security purposes
- “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 6610 Blocking deadly fentanyl imports
H.R. 7776 · 117th Congress
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
2 sections · low confidence
H.R. 6833 · 117th Congress
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
34 sections · high confidence
Show 34 sections and the evidence
Sec. 1001 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1002 Definitions
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1003 Authority to assess and use drug fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1004 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1005 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1006 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1007 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2001 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2002 Definitions
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2003 Authority to assess and use device fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2004 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2005 Conformity assessment pilot program
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2006 Reauthorization of third-party review program
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2007 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2008 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2009 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3001 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3002 Authority to assess and use human generic drug fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3003 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3004 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3005 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3006 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4001 Short title; finding
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4002 Definitions
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4003 Authority to assess and use biosimilar biological product fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4004 Reauthorization; reporting requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4005 Sunset dates
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4006 Effective date
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4007 Savings clause
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 5002 Reauthorization of the humanitarian device exemption incentive
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 5004 Reauthorization of provision pertaining to drugs containing single enantiomers
Sec. 5005 Reauthorization of the critical path public-private partnership
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 5006 Reauthorization of orphan drug grants
- “21 U.S.C. 360ee” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
Sec. 5007 Reauthorization of certain device inspections
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
H.R. 5376 · 117th Congress
Build Back Better Act
9 sections · high confidence
Show 9 sections and the evidence
Sec. 11001 Providing for lower prices for certain high-priced single source drugs
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
- “section 5000D of the Internal Revenue Code of 1986” in the text · Rule d (d:irc-drugs) · high confidence · Source
Sec. 11002 Special rule to delay selection and negotiation of biologics for biosimilar market entry
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 11003 Excise tax imposed on drug manufacturers during noncompliance periods
- “drug manufacturers” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 11101 Medicare part B rebate by manufacturers
Sec. 11102 Medicare part D rebate by manufacturers
Sec. 11201 Medicare part D benefit redesign
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 11301 Extension of moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates
- “prescription drug” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 11406 Appropriate cost-sharing for covered insulin products under Medicare part D
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 11408 Safe harbor for absence of deductible for insulin
- “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
H.R. 3684 · 117th Congress
Investing in a New Vision for the Environment and Surface Transportation in America Act
2 sections · medium confidence
Show 2 sections and the evidence
Sec. 90004 Requiring manufacturers of certain single-dose container or single-use package drugs payable under part B of the Medicare program to provide refunds with respect to discarded amounts of such drugs
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 90006 Moratorium on implementation of rule relating to eliminating the anti-kickback statute safe harbor protection for prescription drug rebates
- “prescription drug” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
H.R. 2617 · 117th Congress
Consolidated Appropriations Act, 2023
97 sections · high confidence
Show 97 sections and the evidence
The “Salaries and Expenses” paragraph Salaries and Expenses
The “Buildings and Facilities” paragraph Buildings and Facilities
- “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
The “Fda Innovation Account, Cures Act” paragraph Fda Innovation Account, Cures Act
- “Food and Drug Administration” in the appropriation account · Rule b (b:fda) · medium confidence · Source
Sec. 722 None of the funds made available by this Act may be used to propose,…
Sec. 737 None of the funds made available by this Act may be used to notify…
Sec. 763 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 774 Notwithstanding any other provision of law, the common name Kanpachi shall serve as an…
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
Sec. 509 (a) None of the funds made available in this Act may be used for…
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 112 Compliance with requirements for examining qualifications and clinical abilities of health care professionals of Department of Veterans Affairs
Sec. 1219 Grants for reducing overdose deaths
Sec. 1220 Opioid overdose reversal medication access and education grant programs
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 1252 Changes to Federal opioid treatment standards
Sec. 1262 Eliminating additional requirements for dispensing narcotic drugs in schedule III, IV, and V for maintenance or detoxification treatment
Sec. 1263 Requiring prescribers of controlled substances to complete training
Sec. 1264 Increase in number of days before which certain controlled substances must be administered
Sec. 1271 Opioid prescription verification
- “21 U.S.C. 829” in the text · Rule a (a:usc-21-csa) · medium confidence · Source
Sec. 1273 Grant program for State and Tribal response to opioid use disorders
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2311 Improving control and oversight of select biological agents and toxins
- “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · high confidence · Source
Sec. 2314 Research to improve biosafety
- “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
Sec. 2315 Federally-funded research with enhanced pathogens of pandemic potential
- “42 U.S.C. 262a” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
Sec. 2331 Advanced Research Projects Agency–Health
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 2401 Warm base manufacturing capacity for medical countermeasures
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2410 Study on incentives for domestic production of generic medicines
- “21 U.S.C. 355” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
Sec. 2411 Increased manufacturing capacity for certain critical antibiotic drugs
Sec. 2501 Accelerating countermeasure development and review
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2502 Third party test evaluation during emergencies
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2503 Platform technologies
Sec. 2504 Increasing EUA decision transparency
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2505 Improving FDA guidance and communication
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 2511 Ensuring registration of foreign drug and device manufacturers
Sec. 2512 Extending expiration dates for certain drugs
Sec. 2513 Combating counterfeit devices
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 2514 Preventing medical device shortages
Sec. 2515 Technical corrections
Sec. 3101 Reauthorization of the critical path public-private partnership
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3103 Reauthorization of the humanitarian device exemption incentive
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3105 Reauthorization of provision pertaining to drugs containing single enantiomers
Sec. 3106 Reauthorization of certain device inspections
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3107 Reauthorization of orphan drug grants
- “21 U.S.C. 360ee” in the text · Rule a (a:usc-21-drugs) · high confidence · Source
Sec. 3109 Reauthorization of third-party review program
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3201 Prompt reports of marketing status by holders of approved applications for biological products
Sec. 3202 Improving the treatment of rare diseases and conditions
- “21 U.S.C. 360bb” in the text · Rule a (a:usc-21-drugs) · medium confidence · Source
- “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · medium confidence · Source
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 3203 Emerging technology program
Sec. 3204 National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
Sec. 3205 Public workshop on cell therapies
Sec. 3206 Clarifications to exclusivity provisions for first interchangeable biosimilar biological products
- “42 U.S.C. 262” in the text · Rule a (a:usc-42-biologics) · high confidence · Source
Sec. 3207 GAO report on nonprofit pharmaceutical organizations
- “pharmaceutical” in the heading · Rule f (f:kw-drugmaker) · low confidence · Source
Sec. 3209 Animal testing alternatives
Sec. 3210 Modernizing accelerated approval
Sec. 3211 Antifungal research and development
Sec. 3212 Advancing qualified infectious disease product innovation
Sec. 3213 Advanced manufacturing technologies designation program
Sec. 3221 Safer disposal of opioids
Sec. 3222 Therapeutic equivalence evaluations
Sec. 3223 Public docket on proposed changes to third-party vendors
Sec. 3224 Enhancing access to affordable medicines
Sec. 3301 Dual submission for certain devices
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3303 GAO report on third-party review
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3304 Certificates to foreign governments
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3305 Ensuring cybersecurity of medical devices
Sec. 3306 Bans of devices for one or more intended uses
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3307 Third party data transparency
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 3308 Predetermined change control plans for devices
Sec. 3309 Small business fee waiver
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3401 Protecting infants and improving formula supply
Sec. 3502 Amendments to cosmetic requirements
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3503 Enforcement and conforming amendments
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3504 Records inspection
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3601 Diversity action plans for clinical studies
Sec. 3602 Guidance on diversity action plans for clinical studies
Sec. 3604 Annual summary report on progress to increase diversity in clinical studies
Sec. 3605 Public meeting on clinical study flexibilities initiated in response to COVID–19 pandemic
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 3607 Modernizing clinical trials
Sec. 3611 Device inspections
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3612 Bioresearch monitoring inspections
Sec. 3613 Improving Food and Drug Administration inspections
Sec. 3614 GAO report on inspections of foreign establishments manufacturing drugs
Sec. 3615 Unannounced foreign facility inspections pilot program
Sec. 3616 Enhancing coordination and transparency on inspections
Sec. 3617 Enhancing transparency of drug facility inspection timelines
Sec. 3621 Regulation of certain products as drugs
Sec. 3622 Women’s Health Research Roadmap
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3623 Strategic workforce plan and report
Sec. 3624 Enhancing Food and Drug Administration hiring authority for scientific, technical, and professional personnel
Sec. 3625 Facilities management
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 3626 User fee program transparency and accountability
Sec. 3627 Improving information technology systems of the Food and Drug Administration
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 3628 Reporting on mailroom and Office of the Executive Secretariat of the Food and Drug Administration
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 3629 Facilitating the use of real world evidence
Sec. 3630 Facilitating exchange of product information prior to approval
Sec. 4131 Temporary inclusion of authorized oral antiviral drugs as covered part D drug
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 4135 Access to non-opioid treatments for pain relief
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 502 Increasing access to summer meals for children through EBT and alternative delivery options
- “Food and Drug Administration” in the text · Rule b (b:fda) · medium confidence · Source
Sec. 703 Extension and modification of maintenance fee authority
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 706 Revision of tables regarding covered pesticide registration applications and other covered actions and their corresponding registration service fees
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · medium confidence · Source
H.R. 2471 · 117th Congress
Consolidated Appropriations Act, 2022
10 sections · medium confidence
Show 10 sections and the evidence
The “Salaries and Expenses” paragraph Salaries and Expenses
Sec. 737 None of the funds made available by this Act may be used to notify…
Sec. 766 None of the funds made available by this Act may be used to propose,…
Sec. 768 Out of amounts appropriated to the Food and Drug Administration under title VI, the…
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
Sec. 809 (a) None of the Federal funds contained in this Act may be used to…
Sec. 205 None of the funds made available in this Act for U.S. Customs and Border…
Sec. 509 (a) None of the funds made available in this Act may be used for…
- “Controlled Substances Act” in the text · Rule a (a:act-csa) · low confidence · Source
Sec. 111 FDA authority over products containing nicotine
- “Federal Food, Drug, and Cosmetic Act” in the text · Rule a (a:act-fdca) · low confidence · Source
Sec. 112 Reporting on tobacco regulation activities
Sec. 121 Eligibility exception for the drug discount program due to the COVID–19 public health emergency
- “42 U.S.C. 256b” in the text · Rule a (a:usc-42-340b) · medium confidence · Source
H.R. 1319 · 117th Congress
American Rescue Plan Act of 2021
3 sections · medium confidence
Show 3 sections and the evidence
Sec. 2301 Funding for COVID–19 vaccine activities at the Centers for Disease Control and Prevention
Sec. 2302 Funding for vaccine confidence activities
Sec. 2304 Funding for COVID–19 vaccine, therapeutic, and device activities at the Food and Drug Administration
- “Food and Drug Administration” in the heading · Rule b (b:fda) · medium confidence · Source
22 law-and-industry pairs in all, newest Congress first.